Biogen
Industrial Machinery & Equipment · Dominican Republic · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Km 22 Autopista De Las Americas, Santo D...Phone Number
(809) 549-1004Website
www.biogendr.comRevenue
$23.6 MillionIndustry
About Biogen
Is Biogen your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Biogen recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check if Biogen has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Biogen
Click to see if Biogen had a recent Job posting/layoffs
Biogen, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Biogen has new funding data
Product Launch: Get notified when Biogen launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Biogen is spiking on competitors!
Recommended Actions
Find VP level buyers at Biogen
Find more new buyers
Company Profile Activity
Activity Insights
Biogen is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Biogen is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Biogen.
Biogen Tech Stack
A closer look at the technologies used by Biogen
Biogen News & Media
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings
Biogen stock is trading flat ahead of earnings as analysts await news from the biotech about its fully approved Alzheimer's drug, Leqembi.Biogen's boardroom scandal saddles CEO with first crisis - STAT News
The nomination of a biotech executive who is the mother of a director’s child has created a headache for CEO Chris Viehbacher.Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
The FDA approved Biogen Inc's (NASDAQ: BIIB) Qalsody (tofersen) for amyotrophic lateral sclerosis (ALS) in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene. This indication is approved under accelerated approval based on a reduction in plasma neurofilament light chain (NfL) observed in patients treated with Qalsody. Neurofilaments are proteins released from neurons when damaged, making them a marker of neurodegeneration. Continued approval for this indication may be contingenFDA Approves Biogen's Drug for Rare Form of ALS
The drug, which will be sold as Qalsody by the pharmaceutical company Biogen, targets a genetic cause of a devastating neurological illness. - www.nytimes.com
Top Industrial Machinery & Equipment Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Biogen
Biogen is a global technology leader and manufacturer of clean energy solutions through gasification of a wide variety of biomass and organic waste. Biogen manufactures modular and scalable gasifier solutions from 200 KWe to 1.2MWe equivalents which when deployed can be installed in parallel to meet the gas volume requirements of the site (200KW-20... Read More